Clinical End Points in Coronary Stent Trials
Donald E. Cutlip(Baim Institute for Clinical Research), Patrick W. Serruys(Erasmus MC), Ashley B. Boam(Centre Hospitalier Universitaire de Caen Normandie), Alexandra J. Lansky(Queen Mary University of London), Stephan Windecker(University of Bern), Pascal Vranckx(Jessa Hospital), Laura Mauri(Brigham and Women's Hospital), David J. Cohen(Baim Institute for Clinical Research), Eugène McFadden(Skadden Arps Slate Meagher & Flom), Martial Hamon(Centre Hospitalier Universitaire de Caen Normandie), Gerrit‐Anne van Es(Centre Hospitalier Universitaire de Caen Normandie), Marie‐Angèle Morel(Unknown), Philippe Gabríel Steg(Mount Sinai Hospital), Mitchell W. Krucoff(Duke University), Roxana Mehran(Mount Sinai Hospital)
Cited by 5,418
Related Papers
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
|European Heart Journal|2015|8.3k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
|New England Journal of Medicine|1994|4.5k